GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Obio Technology (shanghai) Corp Ltd (SHSE:688238) » Definitions » EV-to-Revenue

Obio Technology (shanghai) (SHSE:688238) EV-to-Revenue : 16.47 (As of May. 31, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Obio Technology (shanghai) EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Obio Technology (shanghai)'s enterprise value is ¥3,975.2 Mil. Obio Technology (shanghai)'s Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ¥241.4 Mil. Therefore, Obio Technology (shanghai)'s EV-to-Revenue for today is 16.47.

The historical rank and industry rank for Obio Technology (shanghai)'s EV-to-Revenue or its related term are showing as below:

SHSE:688238' s EV-to-Revenue Range Over the Past 10 Years
Min: 9.94   Med: 22.05   Max: 38.9
Current: 16.47

During the past 11 years, the highest EV-to-Revenue of Obio Technology (shanghai) was 38.90. The lowest was 9.94. And the median was 22.05.

SHSE:688238's EV-to-Revenue is ranked worse than
66.5% of 997 companies
in the Biotechnology industry
Industry Median: 7.42 vs SHSE:688238: 16.47

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-31), Obio Technology (shanghai)'s stock price is ¥6.15. Obio Technology (shanghai)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.37. Therefore, Obio Technology (shanghai)'s PS Ratio for today is 16.58.


Obio Technology (shanghai) EV-to-Revenue Historical Data

The historical data trend for Obio Technology (shanghai)'s EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obio Technology (shanghai) EV-to-Revenue Chart

Obio Technology (shanghai) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 28.28 26.15 11.89

Obio Technology (shanghai) Quarterly Data
Jun19 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.20 11.78 13.02 11.89 14.53

Competitive Comparison of Obio Technology (shanghai)'s EV-to-Revenue

For the Biotechnology subindustry, Obio Technology (shanghai)'s EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Obio Technology (shanghai)'s EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Obio Technology (shanghai)'s EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Obio Technology (shanghai)'s EV-to-Revenue falls into.


;
;

Obio Technology (shanghai) EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Obio Technology (shanghai)'s EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3975.179/241.423
=16.47

Obio Technology (shanghai)'s current Enterprise Value is ¥3,975.2 Mil.
Obio Technology (shanghai)'s Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥241.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Obio Technology (shanghai)  (SHSE:688238) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Obio Technology (shanghai)'s PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.15/0.371
=16.58

Obio Technology (shanghai)'s share price for today is ¥6.15.
Obio Technology (shanghai)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Obio Technology (shanghai) EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Obio Technology (shanghai)'s EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Obio Technology (shanghai) Business Description

Traded in Other Exchanges
N/A
Address
Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201321
Obio Technology (shanghai) Corp Ltd is a biotechnology company focusing on the field of gene therapy, focusing on the development of gene therapy vectors, gene function research, drug targets and efficacy for the basic research of gene therapy Research and other CRO services, and provide CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
Executives
You Qing Rui Directors, senior managers
Pan Jun Yi Director
Yang Jia Li Core technical personnel

Obio Technology (shanghai) Headlines

No Headlines